These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 8616985)
1. Micronized progesterone: vaginal and oral uses. Simon JA Clin Obstet Gynecol; 1995 Dec; 38(4):902-14. PubMed ID: 8616985 [No Abstract] [Full Text] [Related]
2. Effect of oral administration of dydrogestrone versus vaginal administration of natural micronized progesterone on the secretory transformation of endometrium and luteal endocrine profile in patients with premature ovarian failure: a proof of concept. Fatemi HM; Bourgain C; Donoso P; Blockeel C; Papanikolaou EG; Popovic-Todorovic B; Devroey P Hum Reprod; 2007 May; 22(5):1260-3. PubMed ID: 17227809 [TBL] [Abstract][Full Text] [Related]
10. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives]. Cianci A; De Leo V Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832 [TBL] [Abstract][Full Text] [Related]
11. Effect of progesterone and its 5 alpha and 5 beta metabolites on symptoms of premenstrual syndrome according to route of administration. Vanselow W; Dennerstein L; Greenwood KM; de Lignieres B J Psychosom Obstet Gynaecol; 1996 Mar; 17(1):29-38. PubMed ID: 8860884 [TBL] [Abstract][Full Text] [Related]
12. [Effects of micronized natural progesterone on the liver during the third trimester of pregnancy]. Benifla JL; Dumont M; Levardon M; Foucher E; Cadiot G; Crenn-Hebert C; Heid M; Lelaidier C; Rosenbaum A; Bernuau J; Erlinger S; Frydman R; Madelenat P Contracept Fertil Sex; 1997 Feb; 25(2):165-9. PubMed ID: 9116778 [TBL] [Abstract][Full Text] [Related]
13. Progesterone for premenstrual syndrome. Med Lett Drugs Ther; 1984 Nov; 26(674):101-2. PubMed ID: 6387416 [No Abstract] [Full Text] [Related]
14. [Nonoral administration of progesterone: results and prospects of the transvaginal route]. De Ziegler D; Seidler L; Schrer E; Bouchard P Rev Med Suisse Romande; 1994 Sep; 114(9):811-7. PubMed ID: 7939114 [No Abstract] [Full Text] [Related]
15. Endometrial response to a cyclic regimen of percutaneous 17beta-estradiol and low-dose vaginal micronized progesterone in women with mild-to-moderate hypertension. Vilodre LC; Osório Wender MC; Sisson de Castro JA; dos Reis FM; Ruschel S; Magalhães JA; Spritzer PM Gynecol Endocrinol; 2003 Aug; 17(4):323-8. PubMed ID: 14503977 [TBL] [Abstract][Full Text] [Related]
16. Factors associated with withdrawal bleeding after administration of oral micronized progesterone in women with secondary amenorrhea. Shangold MM; Tomai TP; Cook JD; Jacobs SL; Zinaman MJ; Chin SY; Simon JA Fertil Steril; 1991 Dec; 56(6):1040-7. PubMed ID: 1743319 [TBL] [Abstract][Full Text] [Related]
17. A meta-analysis of the route of administration of luteal phase support in assisted reproductive technology: vaginal versus intramuscular progesterone. Zarutskie PW; Phillips JA Fertil Steril; 2009 Jul; 92(1):163-9. PubMed ID: 19362303 [TBL] [Abstract][Full Text] [Related]